Multiple Mechanisms are Involved in Salt-Sensitive Hypertension-Induced Renal Injury and Interstitial Fibrosis

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Wei, Shi Yao ^a   Wang, Yu Xiao ^a   Zhang, Qing Fang ^a   Zhao, Shi Lei ^a   Diao, Tian Tian ^a   Li, Jian Si ^a   Qi, Wen Rui ^b   He, Yi Xin ^a   Guo, Xin Yu ^a   Zhang, Man Zhu ^a   Chen, Jian Yu ^a   Wang, Xiao Ting ^a   Wei, Qiu Ju ^a   Wang, Yu ^a   Li, Bing ^a  

^a Medical University   (China)

^b BNU HKBU UNITED INTERNATIONAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDROCHLOROTHIAZIDE; WNT4 PROTEIN; WNT4 PROTEIN, RAT;

ADMINISTRATION AND DOSAGE; ANIMAL; BLOOD PRESSURE; CAPILLARY; COMPLICATION; DAHL RAT; DRUG EFFECT; FIBROSIS; HYPERTENSION; KIDNEY; KIDNEY DISEASE; KIDNEY TUBULE; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PODOCYTE; SALT INTAKE; TOXICITY; URINE; VASCULARIZATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CAPILLARIES; FIBROSIS; HYDROCHLOROTHIAZIDE; HYPERTENSION; KIDNEY; KIDNEY DISEASES; KIDNEY TUBULES; MALE; PODOCYTES; RATS, INBRED DAHL; SODIUM CHLORIDE, DIETARY; WNT4 PROTEIN;

EID: 85017112121     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep45952     Document Type: Article

References (43)

1. Chobanian, A. V. et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 289, 2560-2572 (2003).
2. Weinberger, M. H. Salt sensitivity of blood pressure in humans. Hypertension. 27, 481-490 (1996).
3. Sterzel, R. B. et al. Renal disease and the development of hypertension in salt-sensitive Dahl rats. Kidney Int. 33, 1119-1129 (1988).
4. Mancia, G. et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. European Heart Journal. 34, 2159-2219 (2013).
5. Obara, T. et al. Awareness of the Japanese Society of Hypertension Guidelines for the Management of Hypertension and their use in clinical practices: 2009 survey results. Hypertens Res. 38, 400-4 (2015).
6. Li, B. et al. Mobilized human hematopoietic stem/progenitor cells promote kidney repair after ischemia/reperfusion injury. Circulation. 121, 2211-2220 (2010).
7. Li, B. et al. Bone marrow cell infusion ameliorates progressive glomerulosclerosis in an experimental rat model. Kidney Int. 69, 323-330 (2006).
8. Kaukinen, A. et al. Peritubular capillaries are rarefied in congenital nephrotic syndrome of the Finnish type. Kidney Int. 75, 1099-1108 (2009).
9. Lindenmeyer, M. T. et al. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol. 18, 1765-1776 (2007).
10. Schilling, T., Miralles, F. & Eder, C. TRPM7 regulates proliferation and polarisation of macrophages. J Cell Sci. 127, 4561-4566 (2014).
11. Ricardo, S. D., van Goor, H. & Eddy, A. A. Macrophage diversity in renal injury and repair. J Clin Invest. 118, 3522-3530 (2008).
12. Li, B. et al. The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair. FASEB J. 24, 4767-4781 (2010).
13. Lin, S. L. et al. Macrophage Wnt7b is critical for kidney repair and regeneration. Proc Natl Acad Sci USA 107, 4194-4199 (2010).
14. Isbel, N. M. et al. Tubules are the major site of M-CSF production in experimental kidney disease: Correlation with local macrophage proliferation. Kidney Int. 60, 614-625 (2001).
15. Yang, N. et al. Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidney. Nephrol Dial Transplant. 13, 1967-1974 (1988).
16. Carroll, T. J. et al. Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev Cell. 9, 283-292 (2005).
17. Surendran, K., Schiavi, S. & Hruska, K. A. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol. 16, 2373-2384 (2005).
18. Zhou, L., Li, Y., Zhou, D., Tan, R. J. & Liu, Y. Loss of Klotho contributes to kidney injury by derepression of Wnt/beta-catenin signaling. J Am Soc Nephrol. 24, 771-785 (2013).
19. Pulkkinen, K., Murugan, S. & Vainio, S. Wnt signaling in kidney development and disease. Organogenesis. 4, 55-59 (2008).
20. Surendran, K., McCaul, S. P. & Simon, T. C. A role for Wnt-4 in renal fibrosis. Am J Physiol Renal Physiol. 282, 431-441 (2001).
21. Li, J. S. et al. Angiopoietin-Like-4, a Potential Target of Tacrolimus, Predicts Earlier Podocyte Injury in Minimal Change Disease. PloS one. 10, e0137049 (2015).
22. Peng, L. et al. The calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4. PloS one 9, e106164 (2014).
23. Zeisberg, M. & Neilson, E. G. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol. 21, 1819-1834 (2010).
24. Yang, L., Besschetnova, T. Y., Brooks, C. R., Shah, J. V. & Bonventre, J. V. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med. 16, 535-543 (2010).
25. He, W., Dai, C., Li, Y., Zeng, G., Monga, S. P. & Liu, Y. Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol. 20, 765-776 (2009).
26. Zhao, S. L. et al. Wnt4 is a novel biomarker for the early detection of kidney tubular injury after ischemia/reperfusion injury. Sci. Rep. 6, 32610, doi: 10.1038/srep32610 (2016).
27. Terada, Y. et al. Expression and Function of the Developmental Gene Wnt-4 during Experimental Acute Renal Failure in Rats. J Am Soc Nephrol. 14, 1223-1233 (2003).
28. Shehata, M. F. Genetic and dietary salt contributors to insulin resistance in Dahl salt-sensitive (S) rats. Cardiovasc Diabetol. 7, 7 (2008).
29. Dvorak, M. M. et al. Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-transporter in bone. J Am Soc Nephrol. 18, 2509-2516 (2007).
30. Basile, D. P., Donohoe, D., Roethe, K. & Osborn, J. L. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol. 281, F887-899 (2001).
31. Shimizu, A., Yamada, K., Sachs, D. H. & Colvin, R. B. Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis. Kidney Int. 61, 1867-1879 (2002).
32. Lin, S. L. et al. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol. 173, 1617-1627 (2008).
33. Chen, Y. T. et al. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int. 80, 1170-1181 (2011).
34. Duffield, J. S. Macrophages in kidney repair and regeneration. J Am Soc Nephrol. 22, 199-201 (2011).
35. Hye Khan, M. A. et al. Orally active epoxyeicosatrienoic acid analog attenuates kidney injury in hypertensive Dahl salt-sensitive rat. Hypertension. 62, 905-913 (2013).
36. Kawakami, T., Ren, S. & Duffield, J. S. Wnt signalling in kidney diseases: dual roles in renal injury and repair. J Pathol. 229, 221-231 (2013).
37. Akhmetshina, A. et al. Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat Commun. 3, 735 (2012).
38. Guo, Y., Xiao, L., Sun, L. & Liu, F. Wnt/beta-catenin signaling: a promising new target for fibrosis diseases. Physiol Res. 61, 337-346 (2012).
39. Cui, R. et al. Multiple mechanisms in renal artery stenosis-induced renal interstitial fibrosis. Nephron Exp Nephrol. 128, 57-66 (2014).
40. Chen, X. et al. Overexpression of Heme Oxygenase-1 Prevents Renal Interstitial Inflammation and Fibrosis Induced by Unilateral Ureter Obstruction. Plos One. 11, e0147084 (2016).
41. Ren, S. et al. LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1. Proc Natl Acad Sci USA 110, 1440-1445 (2013).
42. Coca, S. G. et al. Urinary biomarkers of AKI and mortality 3 years after cardiac surgery. J Am Soc Nephrol. 25, 1063-1071 (2014).
43. Yamada, Y. et al. Mechanism underlying the efficacy of combination therapy with losartan and hydrochlorothiazide in rats with salt-sensitive hypertension. Hypertens Res. 34, 809-816 (2011).